DOI: https://doi.org/10.22263/2312-4156.2016.4.25
Akulionak A.U., Kozlovsky V.I.
Differentiated use of antihypertensive drugs: focus on endothelium and erythrocytes damage
Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Vitebsk, Republic of Belarus
Vestnik VGMU. 2016;15(4):25-32.
Abstract.
Objectives. To substantiate the differentiated use of antihypertensive drugs with endothelium and erythrocytes damage taken into account.
Material and methods. The number of circulating endothelial cells, the level of free hemoglobin were measured in 74 patients with arterial hypertension of the 2nd degree when applying various combinations of antihypertensive agents. The number of adverse cardiovascular events within 6,4±1,7 years of observation was determined.
Results. The increase in the number of circulating endothelial cells, the level of free hemoglobin is associated with an increased risk of myocardial infarctions, strokes, deaths in patients with hypertension of the 2nd degree within 6,4±1,7 years. The use of the combination «lisinopril+hydrochlorothiazide+amlodipine» was accompanied by the most pronounced reduction in the prognostically unfavorable number of circulating endothelial cells and the level of free hemoglobin in comparison with two-component combination «lisinopril+hydrochlorothiazide» (p<0,05).
Conclusions. The increase in the level of markers of endothelium and erythrocytes damage is a predictor of unfavorable medium-term prognosis in arterial hypertension and a determinant of the possibility to use antihypertensive agents differentially.
Key words: arterial hypertension, endothelium, erythrocytes, prognosis, antihypertensive drugs.
References
1. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007 Aug;370(9587):591-603.
2. Arikan E, Sen S. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors. Clin Appl Thromb Hemost. 2005 Apr;11(2):147-59.
3. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005 Dec;115(12):3409-17.
4. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Endothelium, aging, and hypertension. Curr Hypertens Rep. 2006 Apr;8(1):84-9.
5. van den Born BJ, Löwenberg EC, van der Hoeven NV, de Laat B, Meijers JC, Levi M, et al. Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. J Hypertens. 2011 May;29(5):922-7.
6. Jeney V, Balla G, Balla J. Red blood cell, hemoglobin and heme in the progression of atherosclerosis. Front Physiol. 2014 Oct;5:379.
7. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012 Jul;33(13):1635-701.
8. Staessen JA, Birkenhäger WH. Evidence that new antihypertensives are superior to older drugs. Lancet. 2005 Sep;366(9489):869-71.
9. Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005 Sep;366(9489):907-13.
10. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003 Jun;41(6):1281-6.
11. Mrochek AG, Nechesova TA, Korobko IYu, Liventseva MM, Pavlova OS, Pristrom AM. Diagnostika, lechenie i profilaktika arterial'noi gipertenzii [Diagnostics, treatment and prophylaxis of arterial hypertension]: nats rek. Minsk, RB; 2010. 52 р.
12. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemoslov. 1978;27(2):140-4.
13. Kozlovskiy VI, Akulenok AV, Bykovskiy PP, Nikolaykin SV. Perspektivy ispol'zovaniia v klinicheskoi praktike benzidinovogo metoda opredeleniia svobodnogo gemoglobina v krovi [Prospects of use in clinical practice benzidine a method of definition of a free hemoglobin in a blood]. Vestn VGMU. 2009;8(3):53-60.
14. Rebrova OYu. Statisticheskii analiz meditsinskikh dannykh. Primenenie paketa prikladnykh programm STATISTICA [Statistical analysis of medical data. Use of a package of the STATISTICA application programs]. Moscow, RF: Media Sfera; 2002. 312 р.
15. Boos CJ, Lane DA, Karpha M, Beevers DG, Haynes R, Lip GY. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest. 2007 Nov;132(5):1540-7.
16. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005 Apr;293(13):1653-62.
17. Félétou M, Köhler R, Vanhoutte PM. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep. 2010 Aug;12(4):267-75.
Information about authors:
Akulionak A.U. – senior teacher of the Chair of General and Clinical Pharmacology with the course of the Faculty for Advanced Training & Retraining, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University»;
Kozlovsky V.I. – Doctor of Medical Sciences, professor, head of the Chair of Faculty Therapy, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University».
Correspondence address: Republic of Belarus, 210023, Vitebsk, 27 Frunze ave., Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Chair of General and Clinical Pharmacology with the course of the Faculty for Advanced Training & Retraining. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Akulionak Aliaksandr U.
